We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Xponential Fitness
XPOF
$211M
| $11.6M | 0.02% |
671,692
-343,418
| -34% | -$9.72M |
|
|
ODP
652
DELISTED
ODP
ODP
| $11.6M | 0.02% |
247,424
+190,114
| +332% | +$8.16M |
|
653
Golar LNG
GLNG
$5.13B
| $11.6M | 0.02% |
573,658
+260,031
| +83% | +$5.59M |
|
654
Alphatec Holdings
ATEC
$1.44B
| $11.6M | 0.02% |
642,541
+453,291
| +240% | +$7.06M |
|
655
US Physical Therapy
USPH
$1.22B
| $11.5M | 0.02% |
+94,758
| New | +$10.2M |
|
656
Gaming and Leisure Properties
GLPI
$12.8B
| $11.5M | 0.02% |
+237,015
| New | +$11.8M |
|
657
CALL
Johnson & Johnson
JNJ
$625B
| $11.5M | 0.02% |
69,200
-6,600
| -9% | -$1.07M |
|
658
Twilio
TWLO
$36.6B
| $11.4M | 0.02% |
179,391
-115,232
| -39% | -$6.8M |
|
659
PUT
Applied Materials
AMAT
$428B
| $11.4M | 0.02% |
+78,900
| New | +$9.88M |
|
660
McCormick & Company Non-Voting
MKC
$14.2B
| $11.4M | 0.02% |
130,612
-418,477
| -76% | -$37M |
|
|
DOC
661
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $11.3M | 0.02% |
809,759
-101,505
| -11% | -$1.44M |
|
662
O'Reilly Automotive
ORLY
$76.3B
| $11.3M | 0.02% |
177,630
-197,370
| -53% | -$12.1M |
|
663
Flowers Foods
FLO
$1.57B
| $11.3M | 0.02% |
454,582
+420,811
| +1,246% | +$11.1M |
|
664
PUT
NVIDIA
NVDA
$5.42T
| $11.2M | 0.02% |
265,000
-734,000
| -73% | -$24.4M |
|
665
Manulife Financial
MFC
$73.5B
| $11.1M | 0.02% |
589,561
-619,444
| -51% | -$11.8M |
|
|
MZTI
666
The Marzetti Company
MZTI
$3.11B
| $11.1M | 0.02% |
55,420
+39,205
| +242% | +$7.95M |
|
667
Sabre
SABR
$835M
| $11.1M | 0.02% |
3,487,290
+2,928,138
| +524% | +$10.6M |
|
668
CALL
Chipotle Mexican Grill
CMG
$41.5B
| $11.1M | 0.02% |
260,000
+20,000
| +8% | +$791K |
|
669
PUT
Broadcom
AVGO
$2.04T
| $11.1M | 0.02% |
128,000
+87,000
| +212% | +$6.2M |
|
670
iShares MSCI South Korea ETF
EWY
$24.1B
| $11.1M | 0.02% |
175,115
+148,214
| +551% | +$9.28M |
|
671
Sumitomo Mitsui Financial
SMFG
$164B
| $11.1M | 0.02% |
1,289,181
-2,314,600
| -64% | -$19.1M |
|
672
Arthur J. Gallagher & Co
AJG
$63.6B
| $11.1M | 0.02% |
50,417
+48,702
| +2,840% | +$10.1M |
|
673
10x Genomics
TXG
$6.61B
| $11M | 0.02% |
+197,321
| New | +$10.7M |
|
674
International Seaways
INSW
$4.57B
| $11M | 0.02% |
287,499
+115,375
| +67% | +$4.42M |
|
|
SOVO
675
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $11M | 0.02% |
560,731
+397,321
| +243% | +$7.17M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.